Contraindicated (one)pentobarbital will decrease the extent or effect of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is answerable for the development and elimination of cariprazine's active metabolites.pentobarbital will lessen the extent or influence of bortezomib by impacting hepatic/intestinal e